ePrivacy and GPDR Cookie Consent by TermsFeed Generator

IMATINIB TEVA PHARMA

400MG TBL FLM 30 I

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 03.09.2020
Resumption of marketing 15.08.2017
Interruption of marketing 15.08.2017 0028028, 0028386
Placing on the market 22.12.2016

All reports are available in the Overview.

Back to list